Company Filing History:
Years Active: 2007-2008
Title: Swen Hölder: Innovator in Pharmaceutical Chemistry
Introduction
Swen Hölder is a prominent inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyridazinone derivatives. With a total of 2 patents to his name, Hölder continues to push the boundaries of pharmaceutical research.
Latest Patents
Hölder's latest patents focus on novel pyridazinone derivatives, which are crucial in the development of new pharmaceuticals. His work on "Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them" showcases his commitment to advancing medical science. These derivatives are characterized by a general formula (I) that holds promise for various therapeutic applications.
Career Highlights
Swen Hölder is currently employed at Sanofi-Aventis Deutschland GmbH, a leading global healthcare company. His role at Sanofi allows him to collaborate with other experts in the field and contribute to groundbreaking research in pharmaceuticals. His dedication to innovation has positioned him as a key player in the pharmaceutical industry.
Collaborations
Hölder has had the opportunity to work alongside talented colleagues such as Thorsten Naumann and Karl Schönafinger. These collaborations have enriched his research and fostered an environment of creativity and innovation.
Conclusion
Swen Hölder's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and showcases the importance of innovation in the pharmaceutical industry.